nodes	percent_of_prediction	percent_of_DWPC	metapath
Rimonabant—Mood alteration NOS—Capecitabine—esophageal cancer	0.0218	0.0774	CcSEcCtD
Rimonabant—Memory loss—Cisplatin—esophageal cancer	0.0202	0.0717	CcSEcCtD
Rimonabant—Mood alteration NOS—Methotrexate—esophageal cancer	0.0163	0.0576	CcSEcCtD
Rimonabant—CYP2C9—Capecitabine—esophageal cancer	0.0161	0.665	CbGbCtD
Rimonabant—Night sweats—Capecitabine—esophageal cancer	0.00812	0.0288	CcSEcCtD
Rimonabant—CYP2C9—Cisplatin—esophageal cancer	0.00809	0.335	CbGbCtD
Rimonabant—Infection—Carboplatin—esophageal cancer	0.00718	0.0255	CcSEcCtD
Rimonabant—Hiccups—Cisplatin—esophageal cancer	0.00594	0.0211	CcSEcCtD
Rimonabant—Contusion—Capecitabine—esophageal cancer	0.00502	0.0178	CcSEcCtD
Rimonabant—Amnesia—Cisplatin—esophageal cancer	0.00459	0.0163	CcSEcCtD
Rimonabant—Hiccups—Capecitabine—esophageal cancer	0.00438	0.0155	CcSEcCtD
Rimonabant—Irritability—Cisplatin—esophageal cancer	0.00412	0.0146	CcSEcCtD
Rimonabant—Cramp muscle—Cisplatin—esophageal cancer	0.00389	0.0138	CcSEcCtD
Rimonabant—Sleep disorder—Capecitabine—esophageal cancer	0.00367	0.013	CcSEcCtD
Rimonabant—Gastroenteritis—Capecitabine—esophageal cancer	0.00359	0.0127	CcSEcCtD
Rimonabant—Abdominal discomfort—Cisplatin—esophageal cancer	0.00358	0.0127	CcSEcCtD
Rimonabant—Hot flush—Capecitabine—esophageal cancer	0.0034	0.0121	CcSEcCtD
Rimonabant—Amnesia—Capecitabine—esophageal cancer	0.00339	0.012	CcSEcCtD
Rimonabant—Menopausal symptoms—Capecitabine—esophageal cancer	0.00337	0.012	CcSEcCtD
Rimonabant—Lethargy—Capecitabine—esophageal cancer	0.00325	0.0115	CcSEcCtD
Rimonabant—Irritability—Capecitabine—esophageal cancer	0.00304	0.0108	CcSEcCtD
Rimonabant—Mood swings—Capecitabine—esophageal cancer	0.00301	0.0107	CcSEcCtD
Rimonabant—Connective tissue disorder—Cisplatin—esophageal cancer	0.00293	0.0104	CcSEcCtD
Rimonabant—Influenza—Capecitabine—esophageal cancer	0.00275	0.00975	CcSEcCtD
Rimonabant—Mediastinal disorder—Cisplatin—esophageal cancer	0.00269	0.00954	CcSEcCtD
Rimonabant—Abdominal discomfort—Capecitabine—esophageal cancer	0.00264	0.00935	CcSEcCtD
Rimonabant—Malnutrition—Cisplatin—esophageal cancer	0.0026	0.00922	CcSEcCtD
Rimonabant—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.00255	0.00906	CcSEcCtD
Rimonabant—Muscle spasms—Cisplatin—esophageal cancer	0.0025	0.00886	CcSEcCtD
Rimonabant—Infestation NOS—Capecitabine—esophageal cancer	0.00245	0.00869	CcSEcCtD
Rimonabant—Infestation—Capecitabine—esophageal cancer	0.00245	0.00869	CcSEcCtD
Rimonabant—Depression—Capecitabine—esophageal cancer	0.00244	0.00867	CcSEcCtD
Rimonabant—Tremor—Cisplatin—esophageal cancer	0.00243	0.00863	CcSEcCtD
Rimonabant—Lethargy—Methotrexate—esophageal cancer	0.00242	0.00857	CcSEcCtD
Rimonabant—Irritability—Methotrexate—esophageal cancer	0.00226	0.00801	CcSEcCtD
Rimonabant—Convulsion—Cisplatin—esophageal cancer	0.00225	0.00798	CcSEcCtD
Rimonabant—Mood swings—Methotrexate—esophageal cancer	0.00224	0.00795	CcSEcCtD
Rimonabant—Anxiety—Cisplatin—esophageal cancer	0.0022	0.00782	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.0022	0.00779	CcSEcCtD
Rimonabant—Hypoaesthesia—Capecitabine—esophageal cancer	0.00219	0.00776	CcSEcCtD
Rimonabant—Connective tissue disorder—Capecitabine—esophageal cancer	0.00216	0.00767	CcSEcCtD
Rimonabant—Infection—Cisplatin—esophageal cancer	0.00211	0.00747	CcSEcCtD
Rimonabant—Nervous system disorder—Cisplatin—esophageal cancer	0.00208	0.00738	CcSEcCtD
Rimonabant—Skin disorder—Cisplatin—esophageal cancer	0.00206	0.00731	CcSEcCtD
Rimonabant—Hyperhidrosis—Cisplatin—esophageal cancer	0.00205	0.00727	CcSEcCtD
Rimonabant—Anorexia—Cisplatin—esophageal cancer	0.00202	0.00717	CcSEcCtD
Rimonabant—Angiopathy—Capecitabine—esophageal cancer	0.002	0.00708	CcSEcCtD
Rimonabant—Mediastinal disorder—Capecitabine—esophageal cancer	0.00198	0.00703	CcSEcCtD
Rimonabant—Abdominal discomfort—Methotrexate—esophageal cancer	0.00196	0.00696	CcSEcCtD
Rimonabant—Mental disorder—Capecitabine—esophageal cancer	0.00193	0.00684	CcSEcCtD
Rimonabant—Malnutrition—Capecitabine—esophageal cancer	0.00192	0.00679	CcSEcCtD
Rimonabant—Paraesthesia—Cisplatin—esophageal cancer	0.0019	0.00675	CcSEcCtD
Rimonabant—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.0019	0.00675	CcSEcCtD
Rimonabant—Decreased appetite—Cisplatin—esophageal cancer	0.00184	0.00654	CcSEcCtD
Rimonabant—Muscle spasms—Capecitabine—esophageal cancer	0.00184	0.00653	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00183	0.00649	CcSEcCtD
Rimonabant—Infestation NOS—Methotrexate—esophageal cancer	0.00182	0.00647	CcSEcCtD
Rimonabant—Infestation—Methotrexate—esophageal cancer	0.00182	0.00647	CcSEcCtD
Rimonabant—Depression—Methotrexate—esophageal cancer	0.00182	0.00645	CcSEcCtD
Rimonabant—Tremor—Capecitabine—esophageal cancer	0.00179	0.00636	CcSEcCtD
Rimonabant—Anxiety—Capecitabine—esophageal cancer	0.00163	0.00576	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.00162	0.00574	CcSEcCtD
Rimonabant—Dry mouth—Capecitabine—esophageal cancer	0.00159	0.00566	CcSEcCtD
Rimonabant—Infection—Capecitabine—esophageal cancer	0.00155	0.00551	CcSEcCtD
Rimonabant—Nervous system disorder—Capecitabine—esophageal cancer	0.00153	0.00544	CcSEcCtD
Rimonabant—Asthenia—Cisplatin—esophageal cancer	0.00152	0.0054	CcSEcCtD
Rimonabant—Skin disorder—Capecitabine—esophageal cancer	0.00152	0.00539	CcSEcCtD
Rimonabant—Hyperhidrosis—Capecitabine—esophageal cancer	0.00151	0.00536	CcSEcCtD
Rimonabant—Anorexia—Capecitabine—esophageal cancer	0.00149	0.00528	CcSEcCtD
Rimonabant—Angiopathy—Methotrexate—esophageal cancer	0.00149	0.00527	CcSEcCtD
Rimonabant—Mediastinal disorder—Methotrexate—esophageal cancer	0.00148	0.00524	CcSEcCtD
Rimonabant—Diarrhoea—Cisplatin—esophageal cancer	0.00145	0.00515	CcSEcCtD
Rimonabant—Mental disorder—Methotrexate—esophageal cancer	0.00144	0.00509	CcSEcCtD
Rimonabant—Malnutrition—Methotrexate—esophageal cancer	0.00143	0.00506	CcSEcCtD
Rimonabant—Insomnia—Capecitabine—esophageal cancer	0.00141	0.00501	CcSEcCtD
Rimonabant—Paraesthesia—Capecitabine—esophageal cancer	0.0014	0.00498	CcSEcCtD
Rimonabant—Decreased appetite—Capecitabine—esophageal cancer	0.00136	0.00482	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00135	0.00479	CcSEcCtD
Rimonabant—Vomiting—Cisplatin—esophageal cancer	0.00135	0.00478	CcSEcCtD
Rimonabant—Fatigue—Capecitabine—esophageal cancer	0.00135	0.00478	CcSEcCtD
Rimonabant—Rash—Cisplatin—esophageal cancer	0.00134	0.00474	CcSEcCtD
Rimonabant—Dermatitis—Cisplatin—esophageal cancer	0.00134	0.00474	CcSEcCtD
Rimonabant—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00128	0.00453	CcSEcCtD
Rimonabant—Nausea—Cisplatin—esophageal cancer	0.00126	0.00447	CcSEcCtD
Rimonabant—Abdominal pain—Capecitabine—esophageal cancer	0.00124	0.00438	CcSEcCtD
Rimonabant—Convulsion—Methotrexate—esophageal cancer	0.00124	0.00438	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.00121	0.00428	CcSEcCtD
Rimonabant—Infection—Methotrexate—esophageal cancer	0.00116	0.0041	CcSEcCtD
Rimonabant—Nervous system disorder—Methotrexate—esophageal cancer	0.00114	0.00405	CcSEcCtD
Rimonabant—Skin disorder—Methotrexate—esophageal cancer	0.00113	0.00401	CcSEcCtD
Rimonabant—Hyperhidrosis—Methotrexate—esophageal cancer	0.00113	0.00399	CcSEcCtD
Rimonabant—Asthenia—Capecitabine—esophageal cancer	0.00112	0.00398	CcSEcCtD
Rimonabant—Anorexia—Methotrexate—esophageal cancer	0.00111	0.00393	CcSEcCtD
Rimonabant—Pruritus—Capecitabine—esophageal cancer	0.00111	0.00392	CcSEcCtD
Rimonabant—Diarrhoea—Capecitabine—esophageal cancer	0.00107	0.00379	CcSEcCtD
Rimonabant—Insomnia—Methotrexate—esophageal cancer	0.00105	0.00373	CcSEcCtD
Rimonabant—Paraesthesia—Methotrexate—esophageal cancer	0.00105	0.00371	CcSEcCtD
Rimonabant—Dizziness—Capecitabine—esophageal cancer	0.00103	0.00367	CcSEcCtD
Rimonabant—Decreased appetite—Methotrexate—esophageal cancer	0.00101	0.00359	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.001	0.00356	CcSEcCtD
Rimonabant—Fatigue—Methotrexate—esophageal cancer	0.001	0.00356	CcSEcCtD
Rimonabant—Vomiting—Capecitabine—esophageal cancer	0.000994	0.00353	CcSEcCtD
Rimonabant—Rash—Capecitabine—esophageal cancer	0.000986	0.0035	CcSEcCtD
Rimonabant—Dermatitis—Capecitabine—esophageal cancer	0.000985	0.00349	CcSEcCtD
Rimonabant—Headache—Capecitabine—esophageal cancer	0.000979	0.00347	CcSEcCtD
Rimonabant—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000952	0.00337	CcSEcCtD
Rimonabant—Nausea—Capecitabine—esophageal cancer	0.000929	0.00329	CcSEcCtD
Rimonabant—Abdominal pain—Methotrexate—esophageal cancer	0.00092	0.00326	CcSEcCtD
Rimonabant—Asthenia—Methotrexate—esophageal cancer	0.000835	0.00296	CcSEcCtD
Rimonabant—Pruritus—Methotrexate—esophageal cancer	0.000823	0.00292	CcSEcCtD
Rimonabant—Diarrhoea—Methotrexate—esophageal cancer	0.000796	0.00282	CcSEcCtD
Rimonabant—Dizziness—Methotrexate—esophageal cancer	0.00077	0.00273	CcSEcCtD
Rimonabant—CNR2—Signaling Pathways—SST—esophageal cancer	0.000745	0.00107	CbGpPWpGaD
Rimonabant—Vomiting—Methotrexate—esophageal cancer	0.00074	0.00262	CcSEcCtD
Rimonabant—CYP2C9—Biological oxidations—GSTT1—esophageal cancer	0.000739	0.00107	CbGpPWpGaD
Rimonabant—CYP2D6—Biological oxidations—CYP2A6—esophageal cancer	0.000737	0.00106	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—GNG7—esophageal cancer	0.000734	0.00106	CbGpPWpGaD
Rimonabant—Rash—Methotrexate—esophageal cancer	0.000734	0.0026	CcSEcCtD
Rimonabant—Dermatitis—Methotrexate—esophageal cancer	0.000733	0.0026	CcSEcCtD
Rimonabant—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000731	0.00105	CbGpPWpGaD
Rimonabant—CYP2C9—Biological oxidations—CYP2A6—esophageal cancer	0.000731	0.00105	CbGpPWpGaD
Rimonabant—Headache—Methotrexate—esophageal cancer	0.000729	0.00259	CcSEcCtD
Rimonabant—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	0.000727	0.00105	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—GHRL—esophageal cancer	0.000726	0.00105	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—NOTCH3—esophageal cancer	0.000726	0.00105	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—FBXW7—esophageal cancer	0.000714	0.00103	CbGpPWpGaD
Rimonabant—CYP2C9—Arachidonic acid metabolism—PTGS2—esophageal cancer	0.000713	0.00103	CbGpPWpGaD
Rimonabant—CYP2D6—Biological oxidations—PTGS1—esophageal cancer	0.000699	0.00101	CbGpPWpGaD
Rimonabant—CYP2C9—Biological oxidations—PTGS1—esophageal cancer	0.000693	0.000998	CbGpPWpGaD
Rimonabant—Nausea—Methotrexate—esophageal cancer	0.000691	0.00245	CcSEcCtD
Rimonabant—CNR1—Signaling Pathways—XIAP—esophageal cancer	0.000688	0.000991	CbGpPWpGaD
Rimonabant—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000687	0.000991	CbGpPWpGaD
Rimonabant—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	0.000676	0.000975	CbGpPWpGaD
Rimonabant—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000667	0.000961	CbGpPWpGaD
Rimonabant—CYP1A2—Biological oxidations—ALDH2—esophageal cancer	0.000664	0.000957	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—esophageal cancer	0.000651	0.000939	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—NOTCH2—esophageal cancer	0.000651	0.000939	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CTNNA1—esophageal cancer	0.00065	0.000937	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CXCL2—esophageal cancer	0.000647	0.000932	CbGpPWpGaD
Rimonabant—CYP1A2—Biological oxidations—GSTT1—esophageal cancer	0.000632	0.00091	CbGpPWpGaD
Rimonabant—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	0.000629	0.000906	CbGpPWpGaD
Rimonabant—CYP1A2—Biological oxidations—CYP2A6—esophageal cancer	0.000624	0.0009	CbGpPWpGaD
Rimonabant—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	0.00062	0.000894	CbGpPWpGaD
Rimonabant—CYP1A2—Arachidonic acid metabolism—PTGS2—esophageal cancer	0.000609	0.000878	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PSME1—esophageal cancer	0.000604	0.00087	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PSME2—esophageal cancer	0.000604	0.00087	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—ANXA1—esophageal cancer	0.000601	0.000866	CbGpPWpGaD
Rimonabant—CYP2D6—Biological oxidations—CYP1B1—esophageal cancer	0.000594	0.000856	CbGpPWpGaD
Rimonabant—CYP1A2—Biological oxidations—PTGS1—esophageal cancer	0.000592	0.000853	CbGpPWpGaD
Rimonabant—CYP2C9—Biological oxidations—CYP1B1—esophageal cancer	0.000589	0.000849	CbGpPWpGaD
Rimonabant—CYP2D6—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000586	0.000844	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—SST—esophageal cancer	0.000585	0.000843	CbGpPWpGaD
Rimonabant—CYP2C9—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000581	0.000837	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—TGFBR2—esophageal cancer	0.000578	0.000833	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—NOTCH3—esophageal cancer	0.00057	0.000821	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—GHRL—esophageal cancer	0.00057	0.000821	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—esophageal cancer	0.000569	0.000821	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000568	0.000819	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—FBXW7—esophageal cancer	0.000561	0.000808	CbGpPWpGaD
Rimonabant—CYP2D6—Biological oxidations—CYP19A1—esophageal cancer	0.000559	0.000805	CbGpPWpGaD
Rimonabant—CYP2C9—Biological oxidations—CYP19A1—esophageal cancer	0.000554	0.000798	CbGpPWpGaD
Rimonabant—CYP2D6—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000551	0.000794	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—SMAD4—esophageal cancer	0.000547	0.000788	CbGpPWpGaD
Rimonabant—CYP2C9—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000546	0.000787	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—esophageal cancer	0.000542	0.000781	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—EP300—esophageal cancer	0.000542	0.000781	CbGpPWpGaD
Rimonabant—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	0.000512	0.000739	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—NOTCH2—esophageal cancer	0.000511	0.000737	CbGpPWpGaD
Rimonabant—CYP1A2—Biological oxidations—CYP1B1—esophageal cancer	0.000503	0.000725	CbGpPWpGaD
Rimonabant—CYP1A2—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000496	0.000715	CbGpPWpGaD
Rimonabant—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	0.000487	0.000703	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000485	0.0007	CbGpPWpGaD
Rimonabant—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	0.000482	0.000694	CbGpPWpGaD
Rimonabant—CYP1A2—Biological oxidations—CYP19A1—esophageal cancer	0.000473	0.000682	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—MYC—esophageal cancer	0.000472	0.00068	CbGpPWpGaD
Rimonabant—CYP1A2—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000467	0.000673	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—esophageal cancer	0.000462	0.000666	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—esophageal cancer	0.000462	0.000666	CbGpPWpGaD
Rimonabant—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	0.000457	0.000658	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—TGFBR2—esophageal cancer	0.000453	0.000653	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—HIF1A—esophageal cancer	0.000448	0.000645	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—SMAD4—esophageal cancer	0.000429	0.000619	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—KDR—esophageal cancer	0.000428	0.000617	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—NOTCH1—esophageal cancer	0.000403	0.000581	CbGpPWpGaD
Rimonabant—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	0.000388	0.00056	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000384	0.000553	CbGpPWpGaD
Rimonabant—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000383	0.000552	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CREBBP—esophageal cancer	0.000366	0.000527	CbGpPWpGaD
Rimonabant—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	0.000365	0.000526	CbGpPWpGaD
Rimonabant—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	0.00036	0.000519	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—EGFR—esophageal cancer	0.000359	0.000518	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—HIF1A—esophageal cancer	0.000351	0.000506	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000343	0.000495	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—KDR—esophageal cancer	0.000336	0.000484	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000335	0.000482	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000328	0.000473	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—NOS3—esophageal cancer	0.000327	0.000472	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—NOTCH1—esophageal cancer	0.000316	0.000456	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—PIK3CA—esophageal cancer	0.000312	0.000449	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—ERBB2—esophageal cancer	0.000306	0.000441	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—BLVRB—esophageal cancer	0.0003	0.000433	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—SLC52A3—esophageal cancer	0.0003	0.000433	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—SLC52A3—esophageal cancer	0.000298	0.000429	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—BLVRB—esophageal cancer	0.000298	0.000429	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CREBBP—esophageal cancer	0.000287	0.000413	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000286	0.000412	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—EGFR—esophageal cancer	0.000282	0.000406	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CCND1—esophageal cancer	0.00027	0.00039	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000269	0.000388	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000266	0.000383	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CDKN1A—esophageal cancer	0.000262	0.000377	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—NOS3—esophageal cancer	0.000257	0.00037	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CA1—esophageal cancer	0.000255	0.000368	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—SLC10A2—esophageal cancer	0.000255	0.000368	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—SLC52A3—esophageal cancer	0.000254	0.000366	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—BLVRB—esophageal cancer	0.000254	0.000366	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—SLC10A2—esophageal cancer	0.000253	0.000365	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CA1—esophageal cancer	0.000253	0.000365	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—EP300—esophageal cancer	0.000249	0.000359	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—PIK3CA—esophageal cancer	0.000245	0.000353	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—ERBB2—esophageal cancer	0.00024	0.000346	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CA2—esophageal cancer	0.000233	0.000336	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CA2—esophageal cancer	0.000231	0.000333	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000227	0.000328	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000226	0.000326	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PLCE1—esophageal cancer	0.000217	0.000313	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ADH7—esophageal cancer	0.000217	0.000313	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—MYC—esophageal cancer	0.000217	0.000313	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CA1—esophageal cancer	0.000216	0.000312	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—SLC10A2—esophageal cancer	0.000216	0.000312	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ADH7—esophageal cancer	0.000215	0.00031	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PLCE1—esophageal cancer	0.000215	0.00031	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000213	0.000306	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CCND1—esophageal cancer	0.000212	0.000306	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—EGFR—esophageal cancer	0.000212	0.000306	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CDKN1A—esophageal cancer	0.000205	0.000296	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CA2—esophageal cancer	0.000198	0.000285	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—SLC52A3—esophageal cancer	0.000196	0.000283	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—BLVRB—esophageal cancer	0.000196	0.000283	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—EP300—esophageal cancer	0.000195	0.000282	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000193	0.000279	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ADH1B—esophageal cancer	0.00019	0.000274	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ADH1B—esophageal cancer	0.000189	0.000272	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—PIK3CA—esophageal cancer	0.000184	0.000265	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PLCE1—esophageal cancer	0.000184	0.000265	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ADH7—esophageal cancer	0.000184	0.000265	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—TYMP—esophageal cancer	0.000182	0.000262	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000182	0.000262	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—TYMP—esophageal cancer	0.00018	0.00026	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—TP53—esophageal cancer	0.000178	0.000257	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CYP26A1—esophageal cancer	0.000177	0.000255	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CYP26A1—esophageal cancer	0.000175	0.000253	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ALOX15—esophageal cancer	0.000172	0.000248	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ALOX15—esophageal cancer	0.000171	0.000246	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—MYC—esophageal cancer	0.00017	0.000245	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CA1—esophageal cancer	0.000167	0.00024	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—SLC10A2—esophageal cancer	0.000167	0.00024	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—EGFR—esophageal cancer	0.000167	0.00024	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GSTO1—esophageal cancer	0.000164	0.000237	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—TPI1—esophageal cancer	0.000164	0.000237	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GSTO1—esophageal cancer	0.000163	0.000235	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—TPI1—esophageal cancer	0.000163	0.000235	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ADH1B—esophageal cancer	0.000161	0.000232	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ALDOB—esophageal cancer	0.000158	0.000227	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ALDOB—esophageal cancer	0.000156	0.000225	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—TYMP—esophageal cancer	0.000154	0.000222	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CA2—esophageal cancer	0.000153	0.00022	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GAPDH—esophageal cancer	0.000152	0.000219	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GAPDH—esophageal cancer	0.00015	0.000217	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CRABP1—esophageal cancer	0.00015	0.000217	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CYP26A1—esophageal cancer	0.00015	0.000216	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CRABP1—esophageal cancer	0.000149	0.000215	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ALOX15—esophageal cancer	0.000146	0.00021	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PIK3CA—esophageal cancer	0.000145	0.000208	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GNG7—esophageal cancer	0.000143	0.000206	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PLCE1—esophageal cancer	0.000142	0.000204	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ADH7—esophageal cancer	0.000142	0.000204	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GNG7—esophageal cancer	0.000142	0.000204	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—TP53—esophageal cancer	0.00014	0.000201	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GSTO1—esophageal cancer	0.000139	0.000201	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—TPI1—esophageal cancer	0.000139	0.000201	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ALDH2—esophageal cancer	0.000134	0.000193	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ALDOB—esophageal cancer	0.000134	0.000192	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ALDH2—esophageal cancer	0.000133	0.000192	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GAPDH—esophageal cancer	0.000129	0.000185	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GSTT1—esophageal cancer	0.000128	0.000184	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CRABP1—esophageal cancer	0.000127	0.000184	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GSTT1—esophageal cancer	0.000126	0.000182	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CYP2A6—esophageal cancer	0.000126	0.000182	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CYP2A6—esophageal cancer	0.000125	0.00018	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.000124	0.000179	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ADH1B—esophageal cancer	0.000124	0.000179	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GNG7—esophageal cancer	0.000121	0.000175	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ENO1—esophageal cancer	0.000119	0.000172	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PTGS1—esophageal cancer	0.000119	0.000172	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—TYMP—esophageal cancer	0.000119	0.000171	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PTGS1—esophageal cancer	0.000118	0.000171	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ENO1—esophageal cancer	0.000118	0.000171	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PSME2—esophageal cancer	0.000118	0.00017	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PSME1—esophageal cancer	0.000118	0.00017	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PSME1—esophageal cancer	0.000117	0.000168	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PSME2—esophageal cancer	0.000117	0.000168	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CYP26A1—esophageal cancer	0.000116	0.000167	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ALDH2—esophageal cancer	0.000114	0.000164	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ALOX15—esophageal cancer	0.000113	0.000162	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GSTT1—esophageal cancer	0.000108	0.000156	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GSTO1—esophageal cancer	0.000108	0.000155	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—TPI1—esophageal cancer	0.000108	0.000155	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CYP2A6—esophageal cancer	0.000107	0.000154	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.000106	0.000153	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ALDOB—esophageal cancer	0.000103	0.000149	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	0.000102	0.000147	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CYP1B1—esophageal cancer	0.000102	0.000146	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PTGS1—esophageal cancer	0.000101	0.000146	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ENO1—esophageal cancer	0.000101	0.000146	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CYP1B1—esophageal cancer	0.000101	0.000145	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PSME2—esophageal cancer	9.97e-05	0.000144	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PSME1—esophageal cancer	9.97e-05	0.000144	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GAPDH—esophageal cancer	9.92e-05	0.000143	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CRABP1—esophageal cancer	9.83e-05	0.000142	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CYP19A1—esophageal cancer	9.55e-05	0.000138	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CYP19A1—esophageal cancer	9.47e-05	0.000136	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GNG7—esophageal cancer	9.35e-05	0.000135	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ALDH2—esophageal cancer	8.76e-05	0.000126	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—HMOX1—esophageal cancer	8.72e-05	0.000126	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	8.71e-05	0.000126	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—HMOX1—esophageal cancer	8.64e-05	0.000125	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CYP1B1—esophageal cancer	8.61e-05	0.000124	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	8.48e-05	0.000122	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ABCB1—esophageal cancer	8.37e-05	0.000121	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GSTT1—esophageal cancer	8.34e-05	0.00012	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ABCB1—esophageal cancer	8.29e-05	0.00012	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CYP2A6—esophageal cancer	8.24e-05	0.000119	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CYP19A1—esophageal cancer	8.09e-05	0.000117	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PTGS1—esophageal cancer	7.81e-05	0.000113	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ENO1—esophageal cancer	7.81e-05	0.000113	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PSME1—esophageal cancer	7.7e-05	0.000111	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PSME2—esophageal cancer	7.7e-05	0.000111	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—HMOX1—esophageal cancer	7.38e-05	0.000106	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	7.24e-05	0.000104	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ABCB1—esophageal cancer	7.09e-05	0.000102	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CYP1B1—esophageal cancer	6.64e-05	9.57e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	6.27e-05	9.04e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CYP19A1—esophageal cancer	6.24e-05	9e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—HMOX1—esophageal cancer	5.7e-05	8.21e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CREBBP—esophageal cancer	5.59e-05	8.06e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CREBBP—esophageal cancer	5.54e-05	7.99e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ABCB1—esophageal cancer	5.47e-05	7.88e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	5.36e-05	7.72e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—NOS3—esophageal cancer	5.01e-05	7.21e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—NOS3—esophageal cancer	4.96e-05	7.15e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CREBBP—esophageal cancer	4.74e-05	6.83e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PTGS2—esophageal cancer	4.58e-05	6.6e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PTGS2—esophageal cancer	4.54e-05	6.54e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—NOS3—esophageal cancer	4.24e-05	6.11e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PTGS2—esophageal cancer	3.88e-05	5.59e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—EP300—esophageal cancer	3.81e-05	5.49e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—EP300—esophageal cancer	3.78e-05	5.44e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CREBBP—esophageal cancer	3.66e-05	5.27e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—NOS3—esophageal cancer	3.27e-05	4.72e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—EP300—esophageal cancer	3.23e-05	4.65e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PTGS2—esophageal cancer	2.99e-05	4.31e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PIK3CA—esophageal cancer	2.82e-05	4.06e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PIK3CA—esophageal cancer	2.79e-05	4.02e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—EP300—esophageal cancer	2.49e-05	3.59e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PIK3CA—esophageal cancer	2.39e-05	3.44e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.84e-05	2.65e-05	CbGpPWpGaD
